Clinical Trial Update: Pharmacokinetics, Safety and Tolerability of Oral Semaglutide in Subjects With Various Degrees of Impaired Renal Function [Phase 1]

View source ↗

Summary

This Phase 1 study evaluates the pharmacokinetics, safety and tolerability of oral semaglutide in subjects with varying degrees of renal impairment.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Type 2 Diabetes Mellitus

Drugs mentioned

• Rybelsus (oral semaglutide) (semaglutide)

Snippet

Sponsor: Novo Nordisk A/S | Conditions: Diabetes, Diabetes Mellitus, Type 2 | Phase 1 | Status: COMPLETED